TITLE

Reasons for compliance or noncompliance with advice to test for hepatitis C via an internetmediated blood screening service: a qualitative study

AUTHOR(S)
Zuure, Freke R.; Heijman, Titia; Urbanus, Anouk T.; Prins, Maria; Kok, Gerjo; Davidovich, Udi
PUB. DATE
January 2011
SOURCE
BMC Public Health;2011, Vol. 11 Issue 1, p293
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Hepatitis C virus (HCV) is mainly transmitted by exposure to infected blood, and can lead to liver cirrhosis and liver cancer. Since the onset of HCV and the development of liver cirrhosis usually are asymptomatic, many HCVinfected individuals are still undiagnosed. To identify individuals infected with HCV in the general population, a low threshold, internet-mediated blood testing service was set up. We performed a qualitative study examining reasons for compliance and noncompliance with advice to test for HCV via the online blood testing service. Methods: Semistructured telephone interviews were conducted with 33 website visitors who had been advised to test for HCV (18 testers, 15 non-testers). Transcribed interviews were analyzed qualitatively and interpreted using psychosocial theories of health behavior. Results: Reasons for testing pertaining to the online service were: the testing procedure is autonomous, personalized test advice is provided online, reminder emails are sent, and there is an online planning tool. Reasons for testing not specific to the online service were: knowing one's status can prevent liver disease and further transmission of HCV, HCV is curable, testing can provide reassurance, physical complaints are present, and there is liver disease in one's social environment. Service-related reasons for not testing pertained to inconvenient testing facilities, a lack of commitment due to the low threshold character of the service, computer/printing problems, and incorrectly interpreting an online planning tool. The reasons for not testing that are not specific to the online service were: the belief that personal risk is low, the absence of symptoms, low perceived urgency for testing and treatment, fear of the consequences of a positive test result, avoiding threatening information, and a discouraging social environment. Conclusions: Features specific to the online service played a significant role in motivation to test for HCV above and beyond the more conventional perceived health benefits of HCV testing. However, some online specific features were considered problematic and need to be adapted. Methods and strategies for dealing with these impeding factors and for improving compliance with testing via the online service are outlined.
ACCESSION #
62653926

 

Related Articles

  • Optimum Duration of Treatment for Hepatitis C.  // Clinical Oncology Alert;Sep2007 Supplement, Vol. 12 Issue 9, p18 

    The article discusses research being done on the optimum duration of treatment for hepatitis C. It references a study by M. L. Shiffman et al published in the 2007 issue of the "New England Journal of Medicine." The study found that the efficacy of the shorter course of therapy to achieve a...

  • Factors Influencing Treatment Efficacy of 24-Week Combination Therapy with Interferon α-2b Plus Ribavirin for Chronic Hepatitis C. Mitsuhiko Moriyama; Hiroshi Matsumura; Kazushige Nirei; Yasuo Arakawa; Hiroaki Yamagami; Masahiro Ogawa; Miki Kaneko; Shuichi Matsuoka; Shuichi Amaki; Naohide Tanaka; Yasuyuki Arakawa // Digestive Diseases & Sciences;Sep2007, Vol. 52 Issue 9, p2418 

    Abstract  The efficacy of a combination therapy of interferon (IFN) α-2b plus ribavirin (RBV) in chronic hepatitis C, and the factors contributing to efficacy, were investigated. One hundred eighty-six cases were enrolled in this study and treated with a combination of IFN...

  • Predicting response to hepatitis C therapy. Oh, Thomas S.; Rice, Charles M. // Journal of Clinical Investigation;Jan2009, Vol. 119 Issue 1, p5 

    Current treatment for chronic hepatitis C is expensive, is often accompanied by burdensome side effects, and, sadly, fails in almost half of cases. The ability to predict such failures prior to treatment could save a great deal of pain and expense for the patient with HCV. In this issue of the...

  • Complications and Efficiency of Liver Biopsies using the Tru-Cut Biopsy Gun. Cevik, Figen Caglan; Aykin, Nevil; Naz, Hasan // Journal of Infection in Developing Countries;2010, Vol. 4 Issue 2, p91 

    Objectives: The study aimed to evaluate the complications and quality of the specimens of percutaneous liver biopsy in patients with chronic viral hepatitis who were scheduled for treatment and also to evaluate the contribution of the knowledge of ultrasound guided (USG) biopsy localization to...

  • Occult hepatitis B virus infection in Lebanese patients with chronic hepatitis C liver disease. Ramia, S.; Sharara, A.; El-Zaatari, M.; Ramlawi, F.; Mahfoud, Z. // European Journal of Clinical Microbiology & Infectious Diseases;Mar2008, Vol. 27 Issue 3, p217 

    Occult hepatitis B virus (HBV) infection, characterised by the presence of HBV infection with undetectable hepatitis B surface antigen (HBsAg), was investigated in 98 Lebanese patients with chronic hepatitis C liver disease and 85 control subjects recruited from eight institutions in different...

  • Identification of Hydroxyanthraquinones as Novel Inhibitors of Hepatitis C Virus NS3 Helicase. Atsushi Furuta; Masayoshi Tsubuki; Miduki Endoh; Tatsuki Miyamoto; Junichi Tanaka; Kazi Abdus Salam; Nobuyoshi Akimitsu; Hidenori Tani; Atsuya Yamashita; Kohji Moriishi; Masamichi Nakakoshi; Yuji Sekiguchi; Satoshi Tsuneda; Naohiro Noda // International Journal of Molecular Sciences;Aug2015, Vol. 16 Issue 8, p18439 

    Hepatitis C virus (HCV) is an important etiological agent of severe liver diseases, including cirrhosis and hepatocellular carcinoma. The HCV genome encodes nonstructural protein 3 (NS3) helicase, which is a potential anti-HCV drug target because its enzymatic activity is essential for viral...

  • Occult HCV Infection: An Unexpected Finding in a Population Unselected for Hepatic Disease. de Marco, Laura; Gillio-Tos, Anna; Fiano, Valentina; Ronco, Guglielmo; Krogh, Vittorio; Palli, Domenico; Panico, Salvatore; Tumino, Rosario; Vineis, Paolo; Merletti, Franco; Richiardi, Lorenzo; Sacerdote, Carlotta // PLoS ONE;2009, Vol. 4 Issue 12, p1 

    Background: Occult Hepatitis C virus (HCV) infection is a new pathological entity characterized by presence of liver disease and absence or very low levels of detectable HCV-RNA in serum. Abnormal values of liver enzymes and presence of replicative HCV-RNA in peripheral blood mononuclear cells...

  • HEPATITIS C.  // Hepatitis C - General Information;Jun2010, p1 

    The article provides information on Hepatitis C, which is a contagious liver disease resulting from Hepatitis C virus infection. It says that Hepatitis C spread when blood from a person with Hepatitis C virus enters the body of an individual who is not infected. According to the author, testing...

  • Should We Be Screening for Hepatitis C? Scherger, Joseph E. // Internal Medicine Alert;5/15/2008 Pharmacology Watch, Vol. 30, p68 

    Synopsis: Among veterans with risk factors for hepatitis C, a screening program yields results of limited value. The number needed to screen to yield a treatable case of hepatitis C was 451, but the number needed to screen for a successful outcome was more than 4000.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics